IFRX

InflaRx NV News

Company Name Stock Ticker Symbol Market Type
InflaRx NV IFRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.07 -3.2% 2.12 16:34:46
Open Price Low Price High Price Close Price Prev Close
2.15 2.08 2.1666 2.12 2.19
more quote information »

Recent News

Date Time Source Heading
9/09/202207:30GLOBEInflaRx to Present at Upcoming Scientific and Investor..
9/08/202208:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/08/202207:30GLOBEInflaRx Announces Vilobelimab Phase III Results in..
8/05/202207:00GLOBEInflaRx Reports Second Quarter 2022 Financial & Operating..
8/05/202206:10EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/29/202200:13TRMNSVB Securities Reaffirms Their Buy Rating on InflaRx (IFRX)
7/26/202215:05APSBiotech Shares Up Big After Today's Announcement
7/26/202210:52DJNInflaRx Shares Rally on Plans to Seek FDA Emergency-Use..
7/26/202209:05TRMNH.C. Wainwright Thinks InflaRx’s Stock is Going to Recover
7/26/202207:30GLOBEInflaRx Announces Plans to Apply for Emergency Use..
7/06/202209:25TRMNH.C. Wainwright Sticks to Its Buy Rating for InflaRx (IFRX)
7/06/202208:31EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/06/202208:15DJNInflaRx Shares Rise Premarket as Vilobelimab Gets Key FDA..
7/06/202207:30GLOBEInflaRx Receives FDA Fast Track Designation for Treatment of..
7/03/202222:47TRMNSVB Securities Thinks InflaRx’s Stock is Going to Recover
6/29/202208:31EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/29/202207:30GLOBEInflaRx Provides Development Update for Vilobelimab in..
6/29/202203:40TRMNH.C. Wainwright Sticks to Their Buy Rating for InflaRx..
5/17/202207:30GLOBEInflaRx to Present at the H.C. Wainwright Global Investment..
5/12/202212:32TRMNAnalysts Offer Insights on Healthcare Companies: Globus..
5/12/202208:31EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/12/202207:30GLOBEInflaRx Reports First Quarter 2022 Financial and Operating..
4/28/202216:05EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/07/202216:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/03/202205:07TRMNAnalysts’ Top Healthcare Picks: InflaRx (IFRX)
3/31/202212:51TRMNAnalysts Offer Insights on Healthcare Companies: Amylyx..
3/31/202212:39TRMNAnalysts Offer Insights on Healthcare Companies: Amylyx..
3/31/202208:19SEEKInflaRx vilobelimab fails to show statistical significance..
3/31/202207:30GLOBEInflaRx Announces Encouraging Phase III Topline Results from..
3/28/202209:55TRMNH.C. Wainwright Thinks InflaRx’s Stock is Going to Recover
3/25/202208:31TRMNWall Street Analysts Are Bullish on Top Healthcare Picks
3/24/202212:05TRMNH.C. Wainwright Thinks InflaRx’s Stock is Going to Recover
3/24/202209:18EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
3/24/202207:38SEEKInflaRx GAAP EPS of -€1.10
3/24/202207:30GLOBEInflaRx Reports Full Year 2021 Financial and Operating..
3/21/202206:45TRMNAnalysts Are Bullish on These Healthcare Stocks: Armata..
3/18/202208:27TRMNLeerink Partners Thinks InflaRx’s Stock is Going to Recover
3/17/202210:37DJNInflaRx Shares Rise 11% After FDA Sends Corrected Advice..
3/17/202207:30GLOBEInflaRx Receives Corrected Advice Letter from FDA Related to..
3/08/202207:30GLOBEInflaRx Announces Vilobelimab Trial in Pyoderma Gangrenosum..
2/28/202208:59SEEKInflaRx pauses phase 3 trial activities for vilobelimab,..
2/28/202207:30EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/28/202207:30GLOBEInflaRx Provides Update on Development Plans for Vilobelimab..
2/16/202207:30EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/16/202207:30GLOBEInflaRx Reports Progress in Ongoing Phase II Clinical Trial..
2/14/202211:24EDGARAmended Statement of Ownership (sc 13g/a)
2/08/202207:30GLOBEInflaRx to Present at Annual SVB Leerink Global Health..
2/03/202216:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/11/202206:17TRMNInflaRx (IFRX) Receives a Buy from H.C. Wainwright
1/10/202207:31EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..


Your Recent History
NASDAQ
IFRX
InflaRx NV
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now